Identification of novel HDAC inhibitors through cell based screening and their evaluation as potential anticancer agents

Bioorganic & Medicinal Chemistry Letters
2013.0

Abstract

A series of benzimidazole based HDAC inhibitors have been rationally designed, synthesized and screened. The SAR of this new chemotype is described. The lead compound, 11e, showed strong activity in several cellular assays and demonstrated in vivo efficacy in mouse xenograft pancreatic cancer models.

Knowledge Graph

Similar Paper

Identification of novel HDAC inhibitors through cell based screening and their evaluation as potential anticancer agents
Bioorganic & Medicinal Chemistry Letters 2013.0
Discovery of adamantane based highly potent HDAC inhibitors
Bioorganic & Medicinal Chemistry Letters 2013.0
Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents
Bioorganic & Medicinal Chemistry Letters 2014.0
N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: Design, synthesis, SAR studies, and in vivo antitumor activity
Bioorganic & Medicinal Chemistry Letters 2009.0
Design, synthesis and activity evaluation of indole-based double – Branched HDAC1 inhibitors
Bioorganic & Medicinal Chemistry 2019.0
The design, synthesis and structure–activity relationships of novel isoindoline-based histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study
European Journal of Medicinal Chemistry 2017.0
Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors
European Journal of Medicinal Chemistry 2020.0
Novel amide derivatives as inhibitors of histone deacetylase: Design, synthesis and SAR
European Journal of Medicinal Chemistry 2009.0
Design, synthesis and preliminary bioactivity studies of 1,2-dihydrobenzo[d]isothiazol-3-one-1,1-dioxide hydroxamic acid derivatives as novel histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry 2014.0